Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25443250 | 0.99 | BACE1 (0.33) | BACE1PSMB5 | |
| SCHEMBL25443273 | 0.92 | BACE1 (0.36) | BACE1S1PR1S1PR5HRH3 | |
| SCHEMBL25443314 | 0.92 | BACE1 (0.36) | BACE1S1PR1S1PR5HRH3 | |
| SCHEMBL25443310 | 0.92 | BACE1 (0.36) | BACE1S1PR1S1PR5HRH3 | |
| SCHEMBL25443264 | 0.91 | BACE1 (0.34) | BACE1 | |
| SCHEMBL26794194 | 0.89 | BACE1 (0.33) | BACE1PSMB5 | |
| SCHEMBL25443638 | 0.88 | — | — | |
| SCHEMBL25443306 | 0.88 | BACE1 (0.33) | BACE1 | |
| SCHEMBL25443340 | 0.88 | — | — | |
| SCHEMBL25443297 | 0.87 | BACE1 (0.36) | BACE1S1PR1S1PR5HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11653559-B2 | Metal complex containing a first ligand, a second ligand, and a third ligand | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11653559-B2 | Metal complex containing a first ligand, a second ligand, and a third ligand | L1CAM, MLEC, PDCD1LG2 | BACE1 2848/4885PSMB5 3806/4885S1PR1 4593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.